Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?

被引:52
作者
Djavan, B
Zlotta, AR
Remzi, M
Ghawidel, K
Bursa, B
Hruby, S
Wolfram, R
Schulman, CC
Marberger, M
机构
[1] Univ Vienna, Dept Urol, A-1090 Vienna, Austria
[2] Univ Clin Brussels, Dept Urol, Brussels, Belgium
[3] Univ Vienna, Dept Oncol, Vienna, Austria
关键词
D O I
10.1016/S0090-4295(99)00329-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives, To define the role of total prostate (TP) volume, transition zone (TZ) volume, and age as determinants of the utility of prostate-specific antigen (PSA)-based diagnostic parameters for early detection of prostate cancer (PCa) in a prospective multicenter study. Methods. The study participants were 974 consecutive men with serum total PSA (tPSA) levels of 4 to 10 ng/mL who were referred for early PCa detection or lower urinary tract symptoms. All patients underwent prostate ultrasound examination and sextant biopsy with two additional TZ biopsies. In patients with negative initial biopsies, repeated biopsies were performed at 6 weeks. tPSA, the free/total PSA ratio (f/t PSA), PSA density of the TZ (PSA-TZ), PSA density (PSAD), and PSA velocity (PSAV) were determined and compared across TP volume strata of 30 cm(3) or less and greater than 30 cm(3), TZ volume strata of 20 cm(3) or less and greater than 20 cm(3), and various age groups to evaluate the need for volume and/or age-specific reference ranges. Results. PCa was found in 345 (35.4%) of 974 patients and benign prostatic tissue was found in 629 (64.6%) of 947 patients. Across TP volume strata, significantly higher values of tPSA (P <0.01), PSA-TZ, PSAD (P <0.001), and PSAV (P <0.05) and lower values of f/t PSA (P <0.001) were observed in patients with PCa than in those without PCa. Similar results were obtained with respect to TZ volume strata, except in the case of PSAV (P <0.05). tPSA, PSA-TZ, and PSAD were significantly higher (P <0.05) in patients with PCa than in those without PCa for all corresponding age ranges. In patients with PCa, f/t PSA was significantly lower (P <0.001) within the same age ranges. Within each group (PCa or benign), f/t PSA, PSAD, PSA-TZ, and PSAV values were unaffected by age strata. However, PSA parameters dependent on prostate volume (PSAD, PSA-TZ) were statistically lower (P <0.001) in prostates with a higher TP volume (greater than 50 cm(3)) and TZ volume (greater than 20 cm(3)); f/t PSA values were unaffected by TP and TZ volumes. cm Conclusions. f/t PSA and PSA-TZ were the most powerful parameters to differentiate between benign prostatic tissue and PCa. f/t PSA was the sole parameter unaffected by age and prostate volume. We believe new volume-specific cutpoints, as presented in the current study, should be employed when using PSAD and PSA-TZ for the early detection of PCa. UROLOGY 54: 846-852, 1999. (C) 1999, Elsevier Science Inc.
引用
收藏
页码:846 / 852
页数:7
相关论文
共 12 条
[1]   THE USE OF PROSTATE SPECIFIC ANTIGEN DENSITY TO ENHANCE THE PREDICTIVE VALUE OF INTERMEDIATE LEVELS OF SERUM PROSTATE SPECIFIC ANTIGEN [J].
BENSON, MC ;
WHANG, IS ;
OLSSON, CA ;
MCMAHON, DJ ;
COONER, WH .
JOURNAL OF UROLOGY, 1992, 147 (03) :817-821
[2]  
CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214
[3]   COMPARISON OF PROSTATE-SPECIFIC ANTIGEN CONCENTRATION VERSUS PROSTATE-SPECIFIC ANTIGEN DENSITY IN THE EARLY DETECTION OF PROSTATE-CANCER - RECEIVER OPERATING CHARACTERISTIC CURVES [J].
CATALONA, WJ ;
RICHIE, JP ;
DEKERNION, JB ;
AHMANN, FR ;
RATLIFF, TL ;
DALKIN, BL ;
KAVOUSSI, LR ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 152 (06) :2031-2036
[4]   Prostate specific antigen density of the transition zone for early detection of prostate cancer [J].
Djavan, B ;
Zlotta, AR ;
Byttebier, G ;
Shariat, S ;
Omar, M ;
Schulman, CC ;
Marberger, M .
JOURNAL OF UROLOGY, 1998, 160 (02) :411-418
[5]   Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia [J].
Espana, F ;
Martinez, M ;
Royo, M ;
Vera, CD ;
Estelles, A ;
Aznar, J ;
JimenezCruz, JF .
EUROPEAN UROLOGY, 1997, 32 (03) :268-272
[6]  
Lein M, 1998, BRIT J UROL, V82, P231
[7]   RELATIONSHIP BETWEEN PROSTATIC EPITHELIAL VOLUME AND SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS [J].
LEPOR, H ;
WANG, B ;
SHAPIRO, E .
UROLOGY, 1994, 44 (02) :199-205
[8]   SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY-MEN - ESTABLISHMENT OF AGE-SPECIFIC REFERENCE RANGES [J].
OESTERLING, JE ;
JACOBSEN, SJ ;
CHUTE, CG ;
GUESS, HA ;
GIRMAN, CJ ;
PANSER, LA ;
LIEBER, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (07) :860-864
[9]   The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer [J].
Partin, AW ;
Carter, HB .
UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) :531-+
[10]  
Stephan C, 1997, CANCER-AM CANCER SOC, V79, P104, DOI 10.1002/(SICI)1097-0142(19970101)79:1<104::AID-CNCR15>3.0.CO